Cargando…
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
BACKGROUND: Detection of aberrant methylated DNA in the stool is an effective early screening method for colorectal cancer (CRC). Previously, reporters identified that syndecan-2 (SDC2) and tissue factor pathway inhibitor 2 (TFPI2) were aberrantly methylated in most CRC tissues. However, the combine...
Autores principales: | Zhang, Weisong, Yang, Chaogang, Wang, Shuyi, Xiang, Zhenxian, Dou, Rongzhang, Lin, Zaihuan, Zheng, Jinsen, Xiong, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096344/ https://www.ncbi.nlm.nih.gov/pubmed/33958894 http://dx.doi.org/10.2147/CMAR.S300861 |
Ejemplares similares
-
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum]
Publicado: (2022) -
The methylation of SDC2 and TFPI2 defined three methylator phenotypes of colorectal cancer
por: Lei, Ruixue, et al.
Publicado: (2022) -
Methylation of SDC2/TFPI2 and Its Diagnostic Value in Colorectal Tumorous Lesions
por: Zhang, Lianglu, et al.
Publicado: (2021) -
Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
por: Zhao, Guodong, et al.
Publicado: (2020) -
Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
por: Oh, Tae Jeong, et al.
Publicado: (2017)